BioWire Bytes 020 – Morning Coffee May Protect Your Brain for Decades

Summary of a 2026 prospective cohort study in JAMA

I love drinking coffee each morning. It’s a core part of my morning ritual. The smell of freshly ground beans, the warmth of the mug, but most of all, the familiar resulting cognitive “pop”. My mind is immediately more alert, faster, and sharper. This boost is fairly ubiquitous, and probably every startup company in America pulls out the stops for their coffee machine, including at my company where we have a cold brew dispenser. The biology of this short-term effect is well documented. Caffeine blocks adenosine receptors, lifting the brain’s natural brake on arousal. In controlled studies, low-to-moderate doses (about 40-300 mg) reliably improve alertness, vigilance, attention, and reaction time, while effects on memory and higher-order executive function vary more across tasks and settings (McLellan, et al., 2016). But are there any longer-term effects?

The longer question is whether decades of exposure track with slower cognitive decline or lower dementia risk. Recent reviews of the literature suggest a modest signal. A 2024 meta-analysis reported lower dementia risk with higher tea intake and a coffee curve that looks most favorable around 1-3 cups/day (Li, et al., 2024). An updated dose-response meta-analysis found lower risk for “cognitive disorders” with both coffee and tea and a peak around roughly 2.5 cups/day for coffee (Zhu, et al., 2024). However, the foundational studies for these meta-analysis contained some artefacts in the study design, such as short follow-up windows, which can exaggerate apparent benefit. These gaps set the stage for a new JAMA analysis that separates caffeinated from decaffeinated beverages and follows participants across up to four decades.

---

First, if you enjoy these posts, consider subscribing and becoming a part of our growing community!

---

A new prospective analysis in JAMA used repeated diet questionnaires from the Nurses’ Health Study and the Health Professionals Follow-up Study to follow 131,821 U.S. adults for up to 43 years and document 11,033 dementia cases. Coffee, tea, and caffeine intake were modeled as time-dependent covariates, using the cumulative mean of all available food-frequency questionnaires in each follow-up interval to represent habitual intake and reduce within-person random error (Zhang, et al., 2026).

In pooled analyses, participants in the highest quartile of caffeinated coffee intake had an 18% lower hazard of incident dementia compared with the lowest quartile, corresponding to 141 vs 330 cases per 100,000 person-years. Decaffeinated coffee showed no statistically significant association with dementia risk. Tea intake showed a similar direction. In pooled analyses comparing the highest vs lowest tertile of tea intake, the hazard ratio for dementia was 0.86 (95% CI 0.83-0.90), with incidence rates of 201 vs 321 per 100,000 person-years. (Zhang, et al., 2026)

The analysis also linked higher caffeinated beverage intake with subjective and objective cognitive outcomes. Higher caffeinated coffee intake was associated with a lower prevalence of subjective cognitive decline and higher tea intake was associated with a lower prevalence of subjective cognitive decline. In a cognitive testing substudy of older women, higher caffeinated coffee intake was associated with small improvements in Telephone Interview for Cognitive Status scores, while the global cognition composite did not reach conventional statistical significance (P = .06).

Using advanced statistical optimization methodologies, the lowest dementia risk appeared at moderate intake, around 2-3 cups per day of caffeinated coffee or 1-2 cups per day of tea. The authors translate this range to roughly 300 mg of caffeine per day, and the curve plateaus at higher intake levels. This pattern aligns with earlier large-cohort work in UK Biobank, where combined intake of 2-3 cups of coffee plus 2-3 cups of tea per day was associated with a lower dementia hazard (Zhang, et al., 2026; Zhang, et al., 2021).

Caveats remain. These are observational data, and dementia ascertainment relied on death records and self-reported physician diagnoses. The authors report extensive adjustment and sensitivity analyses and did not find meaningful effect modification by smoking status, body mass index, APOE4 genotype, or Alzheimer disease polygenic risk score tertiles, but causality cannot be claimed.

There are still questions regarding the mechanism of caffeinated coffee and tea neuroprotective effects. The most obvious being caffeines antagonistic effect on adenosine receptors, shifting neuronal pathways toward greater excitability and altering downstream dopaminergic and glutamatergic signaling. These pathways are involved in synaptic plasticity, neuroinflammation, and amyloid processing. Those pathways alone make coffee and tea biologically plausible as contributors to cognitive resilience. But there are other effects as well. Coffee and tea carry chlorogenic acids, catechins, and other polyphenols tha tinfluence vascular function and metabolic helath. Cerebral perfusion, endothelial integrity, and insulin sensitivity all subtle track with long-term cognitive outcomes. The JAMA signal clustering around moderate intake suggests a dose response window where neurochemical stimulation and vascular support align without degrading sleep or increasing anxiety.

---

These newsletters take significant effort to put together and are totally for the reader’s benefit. If you find these explorations valuable, there are multiple ways to show your support:

• Engage: Like or comment on posts to join the conversation.

• Subscribe: Never miss an update by subscribing to the Substack.

• Share: Help spread the word by sharing posts with friends directly or on social media.

---

References:

U.S. Food and Drug Administration (n.d.) ‘Spilling the Beans: How Much Caffeine is Too Much?’. Available at: https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much (Accessed: 16 February 2026).

Li, F., Liu, X., Jiang, B. et al. (2024) ‘Tea, coffee, and caffeine intake and risk of dementia and Alzheimer’s disease: a systematic review and meta-analysis of cohort studies’, Food & Function, 15(16), pp. 8330-8344. doi: 10.1039/d4fo01750a.

McLellan, T.M., Caldwell, J.A. and Lieberman, H.R. (2016) ‘A review of caffeine’s effects on cognitive, physical and occupational performance’, Neuroscience & Biobehavioral Reviews, 71, pp. 294-312. doi: 10.1016/j.neubiorev.2016.09.001.

Mirza, S.S., Tiemeier, H., de Bruijn, R.F.A.G. et al. (2014) ‘Coffee consumption and incident dementia’, European Journal of Epidemiology, 29(10), pp. 735-741. doi: 10.1007/s10654-014-9943-y.

Zhang, Y., Yang, H., Li, S. et al. (2021) ‘Consumption of coffee and tea and risk of developing stroke, dementia, and poststroke dementia: a cohort study in the UK Biobank’, PLOS Medicine, 18(11), e1003830. doi: 10.1371/journal.pmed.1003830.

Zhang, Y., Liu, Y., Li, Y. et al. (2026) ‘Coffee and tea intake, dementia risk, and cognitive function’, JAMA. Published online 9 February 2026. doi: 10.1001/jama.2025.27259.

Zhu, Y., Hu, C., Liu, X. et al. (2024) ‘Moderate coffee or tea consumption decreased the risk of cognitive disorders: an updated dose-response meta-analysis’, Nutrition Reviews, 82(6), pp. 738-748. doi: 10.1093/nutrit/nuad089.